Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 18/20 | 0.69 |
| ▸ | MAPK12 | P53778 | 17/20 | 0.69 |
| ▸ | HCK | P08631 | 16/20 | 0.69 |
| ▸ | SRC | P12931 | 3/20 | 0.64 |
| ▸ | GSK3A | P49840 | 2/20 | 0.63 |
| ▸ | SYK | P43405 | 1/20 | 0.63 |
| ▸ | GSK3B | P49841 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12540123 | 0.89 | MAPK14 (0.86) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL20036739 | 0.88 | MAPK14 (0.78) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL19388864 | 0.88 | MAPK14 (0.78) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL13563511 | 0.84 | MAPK14 (0.74) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL20036733 | 0.83 | MAPK14 (0.72) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL2531112 | 0.82 | MAPK14 (0.73) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL12284362 | 0.82 | MAPK14 (0.69) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL20060613 | 0.82 | MAPK12 (0.69) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL20663713 | 0.82 | MAPK14 (0.67) | MAPK14MAPK12HCKSRCGSK3A | |
| SCHEMBL12695287 | 0.82 | MAPK14 (1.00) | MAPK14MAPK12HCKSRCGSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509595-B1 | INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION | RESPIVERT LTD (GB) | 2018-04-11 | — | — | EP | disclosed |